Sign Up Today and Learn More About Inflammatix Stock
Invest in or calculate the value of your shares in Inflammatix or other pre-IPO companies through EquityZen's platform.
Inflammatix Stock (INFM)
Inflammatix develops rapid immune system diagnostics to improve patient care and public health.
About Inflammatix Stock
Founded
2016
Headquarters
Burlingame, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Inflammatix Press Mentions
Stay in the know about the latest news on Inflammatix
Isothermal amplification-based diagnosis and treatment of acute infection
patents • Apr 02, 2025
Systems and methods for assessing a bacterial or viral status of a sample
patents • Apr 02, 2025
Inflammatix Ships TriVerity™ Test Cartridges and Myrna™ Instruments to the U.S. Military
prnewswire • Mar 26, 2025
Fluidic device and methods for characterization of an infection or other …
patents • Feb 07, 2025
Isothermal amplification-based diagnosis and treatment of acute infection
patents • Feb 07, 2025
Inflammatix Management
Leadership team at Inflammatix
Co-Founder and COO
Jonathan Romanowsky
Co-Founder & CEO
Tim Sweeney
Join now and verify your accreditation status to gain access to:
- Inflammatix Current Valuation
- Inflammatix Stock Price
- Inflammatix Management
- Available deals in Inflammatix and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Inflammatix Cap Table and Funding History by Share Class and Liquidity Preferences
- Inflammatix Revenue and Financials
- Inflammatix Highlights
- Inflammatix Business Model
- Inflammatix Risk Factors
- Inflammatix Research Report from SACRA Research
Trading Inflammatix Stock
How to invest in Inflammatix stock?
Accredited investors can buy pre-IPO stock in companies like Inflammatix through EquityZen funds. These investments are made available by existing Inflammatix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Inflammatix stock?
Shareholders can sell their Inflammatix stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
